RY

Rohit Yadav

Active Director Director DIN 08743825
DIN 08743825 First appointment May 2020 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Rohit Yadav

Data last updated:

Rohit Yadav is a Director at Lipsia Pharma Private Limited (since 2020). The company operates in Food And Beverages.

DIN 08743825
Primary Designation Director
Industry Food And Beverages
First Appointment 20 May 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lipsia Pharma Private Limited U24304UP2020PTC128651
Director20 May 20202020Active

Board colleagues of Rohit Yadav

NameDINCompanyDesignation
Anjali Jindal07001543Lipsia Pharma Private LimitedAdditional Director
Jonathan Oliver Byrne08854276Lipsia Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Lipsia Pharma Private Limited
Premium access

Shareholding and investment profile for Rohit Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohit Yadav

Rohit Yadav currently holds 1 directorship: Lipsia Pharma Private Limited (Director, since 20 May 2020).

Rohit Yadav was first appointed on 20 May 2020 as Director at Lipsia Pharma Private Limited.

The current boards of Rohit Yadav's companies include Anjali Jindal (Lipsia Pharma Private Limited), Jonathan Oliver Byrne (Lipsia Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available